Correlation Between Alar Pharmaceuticals and Walsin Lihwa

Can any of the company-specific risk be diversified away by investing in both Alar Pharmaceuticals and Walsin Lihwa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alar Pharmaceuticals and Walsin Lihwa into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alar Pharmaceuticals and Walsin Lihwa Corp, you can compare the effects of market volatilities on Alar Pharmaceuticals and Walsin Lihwa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alar Pharmaceuticals with a short position of Walsin Lihwa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alar Pharmaceuticals and Walsin Lihwa.

Diversification Opportunities for Alar Pharmaceuticals and Walsin Lihwa

0.88

Correlation Coefficient

Alar Pharmaceuticals  Walsin Lihwa

Very poor diversification

The 3 months correlation between Alar and Walsin is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Alar Pharmaceuticals and Walsin Lihwa Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Walsin Lihwa Corp and Alar Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alar Pharmaceuticals are associated (or correlated) with Walsin Lihwa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Walsin Lihwa Corp has no effect on the direction of Alar Pharmaceuticals i.e., Alar Pharmaceuticals and Walsin Lihwa go up and down completely randomly.

Pair Corralation between Alar Pharmaceuticals and Walsin Lihwa

Assuming the 90 days trading horizon Alar Pharmaceuticals is expected to generate 1.41 times more return on investment than Walsin Lihwa. However, Alar Pharmaceuticals is 1.41 times more volatile than Walsin Lihwa Corp. It trades about -0.12 of its potential returns per unit of risk. Walsin Lihwa Corp is currently generating about -0.18 per unit of risk. If you would invest  18,250  in Alar Pharmaceuticals on September 16, 2024 and sell it today you would lose (3,650) from holding Alar Pharmaceuticals or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Alar Pharmaceuticals  vs.  Walsin Lihwa Corp

Alar Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alar Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Walsin Lihwa Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Walsin Lihwa Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Alar Pharmaceuticals and Walsin Lihwa

The main advantage of trading using opposite Alar Pharmaceuticals and Walsin Lihwa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alar Pharmaceuticals position performs unexpectedly, Walsin Lihwa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Walsin Lihwa will offset losses from the drop in Walsin Lihwa's long position.

The idea behind Alar Pharmaceuticals and Walsin Lihwa Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.